Skip to content

The Comparison of success and complication rates followed by central venous line catheterization Insertion between two groups of with and without ultrasound guidance in Open-Heart Surgery Patients

Catheterization With and Without Ultrasound Guidance in Open-Heart Surgery Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240327061372N3
Enrollment
340
Registered
2026-01-29
Start date
2026-02-20
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presence of other specified functional implants. Presence of other specified functional implants

Interventions

Intervention group: Central venous catheter placement using ultrasound guidance Central venous catheter insertion will be performed in both groups by an experienced anesthesiologist. The ca

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years of age who require catheter placement as determined by the medical team Informed consent of the patient or his/her family

Exclusion criteria

Exclusion criteria: Emergency cases that require immediate CV line placement Patients with severe coagulation disorders Anatomical abnormalities at the CV line insertion site History of allergy to disinfectants or equipment used Lack of informed consent from the patient or his/her family

Design outcomes

Primary

MeasureTime frame
Catheter placement success on the first attempt. Timepoint: during catheter placement. Method of measurement: Medical team visit and ABG check.;Pneumothorax. Timepoint: during catheter placement to 24 hours later. Method of measurement: Clinical signs, lung auscultation, radiography.;Hemothorax. Timepoint: during catheter placement. Method of measurement: Clinical signs, radiography.;Cannulation of the artery. Timepoint: during catheter placement. Method of measurement: Medical team visit.;Hematoma. Timepoint: during catheter placement to one week after implantation. Method of measurement: Medical team visit.;Bleeding. Timepoint: during catheter placement. Method of measurement: during catheter placement.;Central vein thrombosis. Timepoint: Up to one week after implantation. Method of measurement: Clinical signs and Doppler ultrasound.;Catheter infection. Timepoint: Up to one week after implantation. Method of measurement: Clinical symptoms, laboratory findings, and catheter tip culture.;Catheter dysfunction. Timepoint: Up to one week after implantation. Method of measurement: impossibility of liquid passage.;Septicemia. Timepoint: Up to one week after implantation. Method of measurement: Clinical symptoms such as fever, Tachycardia, Tachypnea, confusion.

Secondary

MeasureTime frame
Cannulation time. Timepoint: From anesthesia to the end of catheter insertion. Method of measurement: in minutes.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mahdi Kahrom

Mashhad University of Medical Sciences

KahromMH@mums.ac.ir+98 51 3801 2748

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026